Feed MOH
MO

Molina Healthcare MOH · NYSE

$207.36 -2.42% (-$5.14)

Summary

42 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: $4.99B against $3.95B.
  • The share price is below the Bulios Fair Price.
  • It bought back its own shares for $1.00B in the last fiscal year, 9.0% of its market value.
  • Revenue grew by 12% a year over the last 3 years.

What to watch

  • The company made a loss over the last 12 months.
  • Operating profit does not even cover the interest on its debt.
  • Earnings per share fell by 13% a year over the last 3 years.
  • It missed profit estimates 4 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $207.36

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Slowly

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 19% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to fall by 2.1%. Earnings per share fell by 13% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $7.00M.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 14.6 years of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $205.45 is 0.9% below today's price. 44% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

The company reports no revenue by region.

Medicaid Solutions Segment brings in 75% of revenue. Other Segments grew fastest, by 86% a year.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.